10 likes | 99 Views
Develop and Test Curriculum. An IDCAP Laboratory Technologist (Left) conducting individual mentoring to a Site Staff: Photo by Sylvia Munube. ------------------IDCAP Evaluation Design--------------------.
E N D
Develop and Test Curriculum An IDCAP Laboratory Technologist (Left) conducting individual mentoring to a Site Staff: Photo by Sylvia Munube ------------------IDCAP Evaluation Design-------------------- I----------------Year 1 ----------------I---------------- Year 2 ----------------I----------------Year3----------------I Baseline Data Collection Phas1 (18 Sites) IDT (3 week core course before the intervention) IDT Booster 1st and 2nd (At 3 and 6 months respectively) . Distance Learning facilitated by AIDS Treatment Information Center (ATIC) On-Site Support Phase2 (18 Sites) IDT (3 week core course before the intervention) IDT Booster 1st and 2nd (At 3 and 6 months respectively) Distance Learning facilitated by ATIC On-Site Support Collect data and analyze it to evaluate impact of IDCAP on Site Performance and trainees competence Analyze Cost-Effectiveness Document & Disseminate M. Mbonye1, S. Naikoba1, T. Rubashembusya1 , T. Kendle2, S. Kinoti3, L. Mpanga-Sebuyira1, K. Willis2, M. Weaver41. Infectious Diseases Institute, Kampala, Uganda; 2. Accordia Global Health Foundation, Washington, D.C. ; 3. University Research Company – Center for Health Services, Washington D.C.; 4. University of Washington; MF5 after modification by IDCAP Objectives MF5 before modification by UMSP • Results at baseline indicate that; • HIV screening at patient visit especially for patients less than 18 months and TB suspects was very low. • Assessment for pneumonia among patients with a history of cough and no other TB symptoms was low. • Coverage of TB smear exam among suspects was low. • Microscopy among malaria suspects was also low. • Appropriate treatment of malaria was high. • Treatment of patients with malaria negative results was relatively high. • Note that: OSS aims at having a positive impact on site performance on all the indicators. • At 95% Confidence Interval, critical t-value of 2.042 (degrees of freedom = 30), there was no evidence of a statistically significant difference between Phase1 and Phase2 sites in outpatient care performance at baseline. • Integrated Infectious Diseases Capacity Building Evaluation (IDCAP) is an Accordia Global Health Foundation 3 year initiative funded by Bill and Melinda Gates Foundation. • Its goal is to evaluate cost-effectiveness of building capacity of Mid-Level Practitioners (MLP) in care and prevention of infectious diseases in Sub-Saharan Africa • IDCAP is a novel package of classroom training on Integrated Management of Infectious Diseases (IDT), Distance Learning and On-Site Support (OSS) which includes Multi-disciplinary team Training, Individual Clinical Coaching and Continuous Quality Improvement. • It is implemented as a partnership in 36 health facilities in rural Uganda. • To measure the impact of OSS on outpatient care, the Ministry of Health (MoH) Management Information System (HMIS) was strengthened. • 18 sites were randomly assigned to receive OSS for 9 months before the others. • Results of outpatient care performance for IDCAP sites at baseline (Nov ’09 – Mar ’10) are reported. Improving Outpatient Health Information Systems for Integrated Infectious Diseases Management in Rural Uganda Results Baseline outpatient clinical care performance indicators Design • Outpatient performance data on patient visits are collected using a modified MoH Medical Form 5 (MF5). • The HMIS is facilitated with a computer, printer, power backup/supply system, internet powered data transmission equipment and a data entry assistant. This facilitates entry, cleaning, analysis and transmission of MF5 data. • Using the MF5 data, IDCAP tracks 26 indicators. • Total number of patient visits were 238,248 • Health professionals involved in outpatient care routinely complete the MF5. Conclusions • Results indicate that site study randomization was effectively implemented. • Subsequent analysis will compare results of outpatient care performance after 9 months of intervention with those of baseline across each phase. • The MoH now considers adopting the new MF5 to strengthen data and drug supply systems Accordia’s IDCAP Partners Acknowledgments Uganda Malaria Surveillance Project (UMSP) IDCAP implementing health facilities Poster # 169